Our present study first reported that the combination of LAG3 blockade and MWA could extend the survival and postponed tumor development in the MC38 bilateral tumor model, and the combination therapy could reprogram the TME to an anti-tumor manner via promoting the functions of CD8+TILs. The gene discussed is LAG3; the disease is neoplasm.